A crystalline 19-nor c3, 3-disubstituted c21-n-pyrazolyl steroid
MY214961AActive Publication Date: 2026-08-18SAGE THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2022004521
- Authority / Receiving Office
- MY · MY
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2016-08-23
- Filing Date
- 2017-08-23
- Publication Date
- 2026-08-18
- Estimated Expiration
- 2037-08-23
Abstract
This invention relates to a 19-nor C3,3-disubstituted C21-pyrazolyl steroid of Formula (I), Formula (I) and crystalline solid forms and compositions thereof. Also disclosed herein are methods of making crystalline solid forms of the 19-nor C3,3-disubstituted C21-pyrazolyl steroid of Formula (I) and methods of using the 19-nor C3,3-disubstituted C21-pyrazolyl steroid of Formula (I) or crystalline solid forms, pharmaceutically acceptable salts, and pharmaceutically acceptable compositions thereof.
Need to check novelty before this filing date? Find Prior Art